Imiquimod — Discount Pricing
Imiquimod is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.
Imiquimod Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Discount pricing may be available |
| Typical Retail | $102.00 |
Discount pricing may be available; confirm the price with the dispensing pharmacy.
About Imiquimod
Imiquimod is a prescription medication. Ask your doctor if Imiquimod is right for you.
How to Check Imiquimod Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Imiquimod at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Dermatology
About Imiquimod
Imiquimod is a prescription topical medication used to treat various skin conditions. While effective, its cost can sometimes be a barrier. At TheDrugClub, we understand the importance of accessible healthcare. Our membership program is designed to help you save significantly on essential medications like imiquimod, making your treatment plan more manageable and affordable.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What Imiquimod is approved for (FDA label)
Imiquimod cream, 3.75% is indicated for the topical treatment of clinically typical, visible, or palpable actinic keratoses (AK) of the face or balding scalp in immunocompetent adults. (1.1) • Imiquimod cream, 3.75% is indicated for the topical treatment of external genital and perianal warts (EGW) in immunocompetent patients 12 years of age or older. (1.2) 1.1 Actinic Keratosis Imiquimod cream, 3.75% is indicated for the topical treatment of clinically typical, visible or palpable actinic keratoses (AK) of the face or balding scalp in immunocompetent adults. 1.2 External Genital Warts Imiquimod cream, 3.75% is indicated for the topical treatment of external genital and perianal warts (EGW) in immunocompetent patients 12 years of age and older.
Source: Read the full FDA label on DailyMed. Label effective date: January 21, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Dosage forms and strengths for Imiquimod (FDA label)
Imiquimod cream is a white to faintly yellow cream available as: Cream: 3.75%, in unit-dose packets and pump bottles. Each packet contains 0.25 grams of cream and each pump bottle, when actuated after priming, delivers 0.235 grams of cream. Cream: 3.75% in pump bottles or unit-dose packets. ( 3 )
Source: FDA prescribing information (DailyMed). Set ID: 51913a5a-1cab-4b9e-b2c2-e0174062df73. SPL document ID: 48e9d045-e9a2-8452-e063-6294a90af1e9. Label effective date: January 21, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Imiquimod (FDA label)
The following clinically significant adverse reactions are described elsewhere in the labeling: • Local Skin Reactions [see Warnings and Precautions (5.1)] • Systemic Reactions [see Warnings and Precautions (5.2)] Most common adverse reactions (≥4%) are local skin reactions (erythema, scabbing/crusting, flaking/scaling/dryness, edema, erosion/ulceration, exudate,), headache, application site pain, application site irritation, application site pruritus, fatigue, influenza-like illness, and nausea. (6.1) To report SUSPECTED ADVERSE REACTIONS, contact Sun Pharmaceutical Industries, Inc., at 1-866-923-4914 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Source: FDA prescribing information (DailyMed). Set ID: 51913a5a-1cab-4b9e-b2c2-e0174062df73. SPL document ID: 48e9d045-e9a2-8452-e063-6294a90af1e9. Label effective date: January 21, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Imiquimod (FDA label)
None. None. ( 4 )
Source: FDA prescribing information (DailyMed). Set ID: 51913a5a-1cab-4b9e-b2c2-e0174062df73. SPL document ID: 48e9d045-e9a2-8452-e063-6294a90af1e9. Label effective date: January 21, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Warnings and precautions for Imiquimod (FDA label)
Local Skin Reactions: Intense local inflammatory reactions can occur (e.g., skin weeping, erosion). Dosage interruption may be required. Severe vulvar swelling may occur and lead to urinary retention; interrupt dosing or discontinue for severe vulvar swelling. (2.2, 2.3,5.1) Systemic Reactions: Flu-like signs and symptoms have occurred. Consider dosage interruption for systemic reactions. (5.2) Ultraviolet Light Exposure Risks: Avoid or minimize exposure to sunlight and sunlamps. Wear protective clothing. (5.3) 5.1 Local Skin Reactions Local skin reactions including skin weeping or erosion have been reported with use of imiquimod cream and can occur after a few applications [see Adverse Reactions (6)] . Concomitant use of imiquimod cream and any other imiquimod products, in the same treatment area, may increase the risk for and severity of local skin reactions. Imiquimod cream has the potential to exacerbate inflammatory conditions of the skin, including chronic graft versus host disease.
Source: FDA prescribing information (DailyMed). Set ID: 51913a5a-1cab-4b9e-b2c2-e0174062df73. SPL document ID: 48e9d045-e9a2-8452-e063-6294a90af1e9. Label effective date: January 21, 2026. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.